The latest and most exciting developments in biased agonism, in silico modelling, allosterism, signalling & trafficking, structure & mechanism, lead optimisation, preclinal and clinical translation, screening methodologies and medicinal chemistry will be presented.
Hear the latest developments in target discovery and enhance your lead optimisation
Reviewing the past 12 months and looking to the future
- Meet world renowned experts
- Uncover breakthroughs in GPCR structure, function and drug discovery including structural determination details of the CXCR4 chemokine receptor direct from Professor Raymond Stevens, Department of Molecular Biology and
Chemistry, The Scripps Research Institute and Founder of Receptos, USA
- Understand the role of biased agonism and downstream signalling molecules activated by GPCRs and their impact on drug discovery
- Set your work in context
- Learn how the current science is being translated into clinical studies
Who should attend?
- Research & Development Manager
- Project manager
- Project Leader
- Director/VP/President
- Department Head/
- CEO/CSO
- Academic
- Toxicologist
- Senior R&D Scientists
- Screening and Assay Technology
